{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:36:21Z","timestamp":1786782981687,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001231","name":"VicHealth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001169","name":"Cancer Council Tasmania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022513","name":"Tasmanian Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001139","name":"ACT Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT9100003"],"award-info":[{"award-number":["GNT9100003"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.puhe.2025.03.030","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:05:36Z","timestamp":1744643136000},"page":"105718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8830-0520","authenticated-orcid":false,"given":"Joachim","family":"Worthington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8231-7735","authenticated-orcid":false,"given":"Emily","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Carney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-1811","authenticated-orcid":false,"given":"Paul","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4964-3435","authenticated-orcid":false,"given":"Megan","family":"Varlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-6618","authenticated-orcid":false,"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-4694","authenticated-orcid":false,"given":"Eleonora","family":"Feletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2025.03.030_bib1","series-title":"Cancer in Australia 2021","year":"2021"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s13104-020-05395-6","article-title":"Changes in cancer incidence and mortality in Australia over the period 1996\u20132015","volume":"13","author":"Luo","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.puhe.2025.03.030_bib3","series-title":"Cancer Data in Australia","year":"2023"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"10.1016\/j.puhe.2025.03.030_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/imj.15689","article-title":"Hepatocellular carcinoma (HCC) is changing its face: analysis of the temporal trends in aetiology and clinical patterns of HCC in South Australia","volume":"53","author":"Chandran","year":"2023","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib6","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S2468-2667(22)00090-1","article-title":"Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study","volume":"7","author":"Luo","year":"2022","journal-title":"Lancet Public Health"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/imj.16252","article-title":"Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia","volume":"54","author":"Yeoh","year":"2024","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib8","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/hep.28267","article-title":"Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed","volume":"63","author":"Hong","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jhep.2016.09.013","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection","volume":"66","author":"Chayanupatkul","year":"2017","journal-title":"J Hepatol"},{"issue":"20","key":"10.1016\/j.puhe.2025.03.030_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10204638","article-title":"Prevalence of the absence of cirrhosis in subjects with NAFLD-associated hepatocellular carcinoma","volume":"10","author":"Castellana","year":"2021","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.puhe.2025.03.030_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"Stine","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.puhe.2025.03.030_bib14","unstructured":"Australian Institute of Health and Welfare. A Picture of Overweight and Obesity in Australia. Accessed May 8, 2024. doi:10.25816\/5ebcbf95fa7e5."},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib15","doi-asserted-by":"crossref","DOI":"10.5694\/mja2.51096","article-title":"Prevalence of non\u2010alcoholic fatty liver disease in regional Victoria: a prospective population\u2010based study","volume":"215","author":"Roberts","year":"2021","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib16","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib17","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.puhe.2025.03.030_bib18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019-2030","volume":"35","author":"Adams","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.puhe.2025.03.030_bib19","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamainternmed.2019.2248","article-title":"Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"179","author":"Koutoukidis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.puhe.2025.03.030_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154455","article-title":"The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"115","author":"Koutoukidis","year":"2021","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.puhe.2025.03.030_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jhep.2021.07.025","article-title":"Prevention of NAFLD-associated HCC: role of lifestyle and chemoprevention","volume":"75","author":"Lange","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.18773\/austprescr.2022.009","article-title":"Medicines for long-term obesity management","volume":"45","author":"Proietto","year":"2022","journal-title":"Aust Prescr"},{"issue":"10152","key":"10.1016\/j.puhe.2025.03.030_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Griswold","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/add.13757","article-title":"The relationship between different dimensions of alcohol use and the burden of disease\u2014an update","volume":"112","author":"Rehm","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12889-023-15749-x","article-title":"Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis","volume":"23","author":"Niu","year":"2023","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41416-020-01101-2","article-title":"Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over","volume":"124","author":"Sarich","year":"2021","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.puhe.2025.03.030_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1530-0277.2012.01737.x","article-title":"Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers","volume":"36","author":"Trabut","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"12","key":"10.1016\/j.puhe.2025.03.030_bib28","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.14309\/ajg.0000000000001399","article-title":"Impact of alcohol abstinence on the risk of hepatocellular carcinoma in patients with alcohol-related liver cirrhosis","volume":"116","author":"Rodr\u00edguez","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.puhe.2025.03.030_bib29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/adb.12414","article-title":"Harm reduction\u2014a systematic review on effects of alcohol reduction on physical and mental symptoms","volume":"22","author":"Charlet","year":"2017","journal-title":"Addict Biol"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/hepr.12131","article-title":"Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: a systematic review and meta-analysis","volume":"44","author":"Xie","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.puhe.2025.03.030_bib32","series-title":"National Alcohol Strategy 2019-2028","year":"2019"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib34","doi-asserted-by":"crossref","first-page":"G1018","DOI":"10.1152\/ajpgi.00245.2016","article-title":"Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"311","author":"Bluemel","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/bjc.2016.422","article-title":"Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance","volume":"116","author":"Johnson","year":"2017","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","volume":"77","author":"Singal","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2025.03.030_bib37","series-title":"Roadmap to Liver Cancer Control in Australia","year":"2023"},{"issue":"10","key":"10.1016\/j.puhe.2025.03.030_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5694\/mja2.50885","article-title":"Australian recommendations for the management of hepatocellular carcinoma: a consensus statement","volume":"214","author":"Lubel","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.puhe.2025.03.030_bib39","article-title":"Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia","year":"2023","journal-title":"Cancer Council Australia"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12913-023-09360-4","article-title":"Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling study","volume":"23","author":"Nguyen","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.puhe.2025.03.030_bib41","article-title":"An economic evaluation of routine hepatocellular carcinoma surveillance for high-risk patients using a novel approach to modelling competing risks","author":"Worthington","year":"2024","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.puhe.2025.03.030_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.puhe.2025.03.030_bib44","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib46","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.puhe.2025.03.030_bib47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/sono.12198","article-title":"A discussion paper on key issues impacting the sonographer workforce in Australia","volume":"6","author":"Bowman","year":"2019","journal-title":"Sonography"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0006-341X.2004.00023.x","article-title":"An early\u2010 and late\u2010stage convolution model for disease natural history","volume":"60","author":"Pinsky","year":"2004","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jfma.2021.07.013","article-title":"The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: a diagnostic or screening tool?","volume":"121","author":"lan","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"10.1016\/j.puhe.2025.03.030_bib52","article-title":"Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community","volume":"13","author":"Cheng","year":"2018","journal-title":"PLoS ONE Electron Resour"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatol Baltim Md"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2019.07.013","article-title":"Long-term liver-related outcomes of patients with chronic liver diseases in Australia","volume":"18","author":"Huang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"42","key":"10.1016\/j.puhe.2025.03.030_bib55","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.puhe.2025.03.030_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-024-04285-w","article-title":"Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction","author":"Park","year":"2024","journal-title":"Abdom Radiol"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib61","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.puhe.2025.03.030_bib62","article-title":"Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis","author":"Hofer","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.puhe.2025.03.030_bib63","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/jvh.13252","article-title":"Enhancing the hepatitis B care cascade in Australia: a cost\u2010effectiveness model","volume":"27","author":"Xiao","year":"2020","journal-title":"J Viral Hepat"},{"issue":"7143","key":"10.1016\/j.puhe.2025.03.030_bib64","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.316.7143.1529","article-title":"Economics notes: perspectives in economic evaluation","volume":"316","author":"Byford","year":"1998","journal-title":"Br Med J"},{"key":"10.1016\/j.puhe.2025.03.030_bib65","series-title":"Australia, December 2023","year":"2024"},{"issue":"8","key":"10.1016\/j.puhe.2025.03.030_bib66","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jval.2018.01.017","article-title":"Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC\u2014Does the presence of an explicit threshold affect the ICER proposed?","volume":"21","author":"Wang","year":"2018","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.puhe.2025.03.030_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227899","article-title":"Improving Australian national bowel cancer screening program outcomes through increased participation and cost-effective investment","volume":"15","author":"Worthington","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib69","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.puhe.2025.03.030_bib70","series-title":"Clinical Characteristics and Surveillance Patterns in Hepatocellular Carcinoma Patients in Australia","author":"He","year":"2024"},{"issue":"12","key":"10.1016\/j.puhe.2025.03.030_bib71","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","article-title":"Hepatocellular carcinoma surveillance \u2014 utilization, barriers and the impact of changing aetiology","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.puhe.2025.03.030_bib72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31128\/AJGP-02-23-6731","article-title":"New anti-obesity medications: considerations and future directions in people with concurrent eating disorders","volume":"52","author":"Sharp","year":"2023","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.puhe.2025.03.030_bib73","article-title":"Cost-effectiveness of LiveLighter\u00ae - a mass media public education campaign for obesity prevention","volume":"vol. 17","author":"Ananthapavan","year":"2022"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib74","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2020.12.004","article-title":"Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis","volume":"74","author":"Avance\u00f1a","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2025.03.030_bib75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/JMDH.S359084","article-title":"Potential for use of portable ultrasound devices in rural and remote settings in Australia and other developed countries: a systematic review","volume":"15","author":"Shaddock","year":"2022","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.puhe.2025.03.030_bib76","series-title":"Novel Biomarkers of Hepatocellular Carcinoma","author":"Cheng","year":"2018"},{"issue":"3","key":"10.1016\/j.puhe.2025.03.030_bib77","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1055-9965.EPI-18-0281","article-title":"GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score","volume":"28","author":"Yang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.puhe.2025.03.030_bib78","series-title":"Alcohol, Tobacco & Other Drugs in Australia","year":"2024"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib79","first-page":"1","article-title":"Liver disease in aboriginal and Torres Strait Islander people","volume":"3","author":"Tashkent","year":"2022","journal-title":"J Aust Indig Heal."},{"key":"10.1016\/j.puhe.2025.03.030_bib80","unstructured":"Australian Institute of Health and Welfare. Overweight and Obesity. AIHW, Australian Government Accessed April 14, 2023. https:\/\/www.aihw.gov.au\/reports\/australias-health\/overweight-and-obesity."},{"issue":"12","key":"10.1016\/j.puhe.2025.03.030_bib82","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1111\/liv.12853","article-title":"Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia","volume":"35","author":"Clark","year":"2015","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.puhe.2025.03.030_bib83","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1071\/AH17259","article-title":"Disparities in access to health care in Australia for people with mental health conditions","volume":"43","author":"Corscadden","year":"2019","journal-title":"Aust Health Rev"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00535-022-01849-9","article-title":"Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts","volume":"57","author":"Nishida","year":"2022","journal-title":"J Gastroenterol"},{"issue":"7","key":"10.1016\/j.puhe.2025.03.030_bib85","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","article-title":"Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project","volume":"118","author":"Petrick","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.puhe.2025.03.030_bib86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/HMER.S278070","article-title":"Chemical risk factors of primary liver cancer: an update","volume":"12","author":"Barsouk","year":"2021","journal-title":"Hepatic Med"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00428-018-2340-2","article-title":"Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al","volume":"473","author":"Hytiroglou","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.puhe.2025.03.030_bib88","series-title":"Cancer Data in Australia","year":"2024"},{"key":"10.1016\/j.puhe.2025.03.030_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2024.12.009","article-title":"Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer","author":"Lonardo","year":"2025","journal-title":"Trends Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.puhe.2025.03.030_bib90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-nutr-071714-034434","article-title":"Health benefits of long-term weight-loss maintenance","volume":"35","author":"Rueda-Clausen","year":"2015","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"10.1016\/j.puhe.2025.03.030_bib91","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/alcalc\/agn003","article-title":"Alcohol consumption, abstaining, health utility, and quality of life \u2013 a general population survey in Finland","volume":"43","author":"Saarni","year":"2008","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"10.1016\/j.puhe.2025.03.030_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/acps.12330","article-title":"Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden","volume":"131","author":"Westman","year":"2015","journal-title":"Acta Psychiatr Scand"},{"issue":"0","key":"10.1016\/j.puhe.2025.03.030_bib93","article-title":"Evaluating semi-Markov processes and other epidemiological time-to-event models by computing disease sojourn density as partial differential equations","volume":"0","author":"Worthington","year":"2025","journal-title":"Medical Decision Making"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350625001490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350625001490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:05:39Z","timestamp":1762218339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350625001490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":86,"alternative-id":["S0033350625001490"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2025.03.030","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2025.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}],"article-number":"105718"}}